Research Critique of Thiazolidine Analogues
-
Published:2022-10-01
Issue:
Volume:
Page:351-357
-
ISSN:0974-4150
-
Container-title:Asian Journal of Research in Chemistry
-
language:en
-
Short-container-title:AJRC
Author:
Muthuboopathi Gopal1, Rajendran Thirumurthi1, Shanawaz Samina1, Moorthi Dhivya1, Thirunavukkarasu Janani1, Nandhini Nandhini1, Saminathan Vani1
Affiliation:
1. Department of Pharmaceutical Chemistry, Vivekananda Pharmacy College for Women, Sankari – 637303.
Abstract
Contemporary pharmaceutical chemistry faces several challenges in different directions, including the need for both the potency and specificity of any therapeutic agent. The increasingly demanding low toxicity requirements observed in all patients treated and the need for novelty in intellectual property, given the extensive use of benzenoid and heteroaromatic ring systems in many patents. Such challenges are increasingly met by moving to new and / or unusual ring systems (scaffolds) that lie outside the realm of (hetero) aromatic systems. This critical review examines the biological activities of Thiazolidine derivatives like anti-microbial, anti-cancer, anti-diabetics, antiobesity, anti-oxidant by giving mechanistic insights of the given atypical scaffolds from mainly drawn from the literature of the last five years, which have found applications in modern bioorganic chemistry and Medicinal Chemistry.
Publisher
A and V Publications
Reference20 articles.
1. Srikanth Kumar, K., Lakshmana Rao, A., and Sekhara Reddy, D. R. Design, Synthesis, Hypoglycemic Activity and Molecular Docking Studies of 3-substituted-5- [(furan-2-yl)-methylene]-thiazolidine-2,4-dione Derivatives. Indian Journal of Pharmaceutical Education and Research. 2021;55(1), 266–275. https://doi.org/10.55305/ijper.55.1.30 2. National Center for Biotechnology Information. PubChem Compound Summary for CID 10444, Thiazolidine. (2021;https://pubchem.ncbi.nlm.nih.gov/compound/Thiazolidine. 3. De Monte, C., Carradori, S., Bizzarri, B., Bolasco, A., Caprara, F., Mollica, A., Rivanera, D., Mari, E., Zicari, A., Akdemir, A., and Secci, D. Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives. European Journal of Medicinal Chemistry. 2016; 107, 82–96. https://doi.org/10.1016/j.ejmech.2015.10.048 4. Sriram,D., Yogeeshwari,P., Kumar., A.TG. Microwave-assisted synthesis and anti YFV activity of 2,3-diaryl-1-3-thiazolidin-4-one. J Pharmaceut Sci. 2005;8 (3): 426-429. 5. Pires Gouvea, D., Vasconcellos, F. A., dos Anjos Berwaldt, G., Neto, A. C. P. S., Fischer, G., Sakata, R. P., Almeida, W. P., and Cunico, W. 2-Aryl-3-(2-morpholinoethyl)thiazolidin-4-ones: Synthesis, anti-inflammatory in vivo, cytotoxicity in vitro and molecular docking studies. European Journal of Medicinal Chemistry. 2016;118, 259–265. https://doi.org/10.1016/j.ejmech.2016.04.028
|
|